Anumana Appoints Kevin Ballinger and Jean-Luc Butel to Board of Directors

Partnerships

December
16
2022
December 16, 2022

Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development

HIT Consultant: Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm…
December
16
2022
December 16, 2022

New Project Trains AI on a Hard-to-Diagnose Cardiac Issue

Health Leaders: A start-up from the Mayo Clinic orbit is partnering with Pfizer to develop an AI-enhanced ECG that can detect cardiac amyloidosis, a progressive disease that's difficult to diagnose…
December
16
2022
December 16, 2022

Anumana, Pfizer collaborate on AI-based detection of cardiovascular disease

NS Medical Devices: The research agreement with Pfizer will aid Anumana to develop an AI-enabled ECG algorithm to help detect patients who may be at risk of cardiac amyloidosis
December
16
2022
December 16, 2022

Anumana and Pfizer partner for cardiovascular disease detection

Medical Device Network: Health technology company Anumana and Pfizer have signed a multi-year agreement to develop an artificial intelligence electrocardiogram (AI-ECG) algorithm for the early detection of cardiac amyloidosis. Under…
December
16
2022
December 16, 2022

Pfizer links up with heart disease AI developer Anumana to build cardiac amyloidosis diagnostics

FIERCE Biotech: The heart-focused artificial intelligence company Anumana is looking to break new ground for its algorithms through a partnership with Pfizer. They plan to develop programs that can help…
December
15
2022
December 15, 2022

Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

BioSpace: Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has entered into a multi-year agreement with Pfizer Inc. for Anumana to develop an artificial intelligence electrocardiogram…
July
14
2022
July 14, 2022

Novartis turns to algorithms developer Anumana to apply AI to cardio conditions

Med City News: Novartis is partnering with algorithms startup Anumana to develop a new artificial intelligence-based solution for cardiovascular diseases. The goal is to find ways to detect heart conditions…
July
13
2022
July 13, 2022

Anumana Collaborates with Novartis Pharmaceuticals Corporation

AI TechPark: Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of…
July
13
2022
July 13, 2022

Novartis links up with Mayo Clinic spinout Anumana to develop ECG-reading AI

FIERCE Biotech: Heart disease remains the leading cause of death around the world, but a flood of tech developers are hoping that artificial intelligence software might be the key to…
July
13
2022
July 13, 2022

Anumana and Novartis partner for AI-based heart disease detection

NS Medical Devices: Health technology company Anumana has entered into a multi-year strategic collaboration with Novartis Pharmaceuticals to detect heart disease leveraging a series of artificial intelligence (AI)-powered software solutions.…